← Back to Analyst Consensus 
PHIO Buy
Phio Pharmaceuticals Corp.
Current Price —
Implied Upside —
Analysts 7
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 11, 2026 (16 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 26, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Feb 10, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | $14 | 44% |
| Aug 15, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $14 | 44% |
| Jun 25, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $14 | 44% |
| Apr 8, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $4 | 44% |
| Feb 19, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $4 | 44% |
| May 14, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $4 | 44% |
| Feb 6, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $4 | 44% |
| Aug 16, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $6 | 44% |
Price Target Trend
Apr 23, 2026 Latest: $14 Oct 25, 2026
EPS Estimates
+1q $-0.39
Lo: $-0.40 Hi: $-0.37
2 analysts 0y $-1.45
Lo: $-1.47 Hi: $-1.42
2 analysts +1y $-0.61
Lo: $-0.77 Hi: $-0.45
2 analysts ▲1
0q $-0.36
Lo: $-0.37 Hi: $-0.35
2 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days